Clearpoint Neuro Inc (CLPT) has a current Price-to-Book (P/B) ratio of 25.13. Compared to its 3-year average P/B ratio of 11.90, the current P/B ratio is approximately 111.15% higher. Relative to its 5-year average P/B ratio of 11.96, the current P/B ratio is about 110.07% higher. Clearpoint Neuro Inc (CLPT) has a Forward Free Cash Flow (FCF) yield of approximately -3.31%. Compared to its 3-year average FCF yield of -6.24%, the current FCF yield is approximately -46.92% lower. Relative to its 5-year average FCF yield of -5.63%, the current FCF yield is about -41.19% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CLPT competitors is 4.49, providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT.O) exhibits a P/S ratio of 8.36, which is 86.17% above the industry average. Given its robust revenue growth of 9.10%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CLPT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CLPT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CLPT currently overvalued or undervalued?

What is Clearpoint Neuro Inc (CLPT) fair value?

CLPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Clearpoint Neuro Inc (CLPT) is between 5.52 to 15.04 according to relative valuation method.

How does CLPT's valuation metrics compare to the industry average?

The average P/S ratio for CLPT's competitors is 4.49, providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT) exhibits a P/S ratio of 8.36, which is 86.17% above the industry average. Given its robust revenue growth of 9.10%, this premium appears unsustainable.

What is the current P/B ratio for Clearpoint Neuro Inc (CLPT) as of Mar 04 2026?

As of Mar 04 2026, Clearpoint Neuro Inc (CLPT) has a P/B ratio of 25.13. This indicates that the market values CLPT at 25.13 times its book value.

What is the current FCF Yield for Clearpoint Neuro Inc (CLPT) as of Mar 04 2026?

As of Mar 04 2026, Clearpoint Neuro Inc (CLPT) has a FCF Yield of -3.31%. This means that for every dollar of Clearpoint Neuro Inc's market capitalization, the company generates -3.31 cents in free cash flow.

What is the current Forward P/E ratio for Clearpoint Neuro Inc (CLPT) as of Mar 04 2026?

As of Mar 04 2026, Clearpoint Neuro Inc (CLPT) has a Forward P/E ratio of -16.90. This means the market is willing to pay $-16.90 for every dollar of Clearpoint Neuro Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Clearpoint Neuro Inc (CLPT) as of Mar 04 2026?

As of Mar 04 2026, Clearpoint Neuro Inc (CLPT) has a Forward P/S ratio of 8.36. This means the market is valuing CLPT at $8.36 for every dollar of expected revenue over the next 12 months.

CLPT Valuation